Thinking of joining a study?

Register your interest

Become a volunteer?

NCT06868082 | NOT YET RECRUITING | Healthy

A Study to Investigate Safety, Tolerability, and Pharmacokinetics of Solrikitug in Healthy Japanese and Non-Japanese Participants
Sponsor:

Uniquity One (UNI)

Brief Summary:

A Phase 1, Open-Label Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Two Formulations of Subcutaneously Administered Solrikitug in Healthy Japanese and non-Japanese Participants

Condition or disease

Healthy

Intervention/treatment

Solrikitug

Solrikitug

Phase

PHASE1

Study Type : INTERVENTIONAL
Estimated Enrollment : 32 participants
Masking : NONE
Primary Purpose : TREATMENT
Official Title : A Phase 1, Open-Label Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Two Formulations of Subcutaneously Administered Solrikitug in Healthy Japanese and Non-Japanese Participants
Actual Study Start Date : 2025-05-30
Estimated Primary Completion Date : 2025-08-30
Estimated Study Completion Date : 2025-12-31

Information not available for Arms and Intervention/treatment

Ages Eligible for Study: 18 Years to 55 Years
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers: 1
Criteria
Inclusion Criteria
  • * At the time of initial screening, in general good health (age 18 to 55 years);
  • * Participants who are healthy as determined by medical evaluation including medical history, physical examination, laboratory tests and cardiac monitoring
  • * Participant must agree to use contraception during the treatment period and until follow-up
  • * Capable of giving signed informed consent which includes compliance with the requirements and restrictions of the study
Exclusion Criteria
  • * Pregnancy or breastfeeding during the study
  • * Chronic infection
  • * Treatment with prohibited medications.
A Study to Investigate Safety, Tolerability, and Pharmacokinetics of Solrikitug in Healthy Japanese and Non-Japanese Participants

Location Details

NCT06868082

Please Choose a site

How to Participate

Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.

Locations

Not yet recruiting

Australia, Queensland

Research Site

Brisbane, Queensland, Australia,